Skip to search formSkip to main contentSkip to account menu

10-hydroxycamptothecin

Known as: 10-hydroxycamptothecine 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
The objective of this study was to evaluate the feasibility of producing 10-hydroxycamptothecin nanosuspensions with high drug… 
Highly Cited
2008
Highly Cited
2008
A beta-glucuronidase-activated prodrug approach was applied to 10-hydroxycamptothecin, a Camptotheca alkaloid with promising… 
2006
2006
This study explored the feasibility of using surface-modified nanoparticulate drug delivery system to enhance the transepithelial… 
Highly Cited
2003
Highly Cited
2003
Abstract: MDM2 oncogene is overexpressed in many human cancers including breast, colon, and prostate cancer, and MDM2 levels are… 
2000
2000
10-Hydroxycamptothecin (HCPT), a DNA topoisomerase I (Topo I) inhibitor, exhibited a remarkable apoptosis-inducing effect on… 
1998
1998
Recently, natural product DNA topoisomerase I inhibitors 10-hydroxycamptothecin (HCPT) and camptothecin (CPT) have been shown to… 
Highly Cited
1991
Highly Cited
1991
Water-soluble analogues of the antitumor alkaloid camptothecin (1) were prepared in which aminoalkyl groups were introduced into… 
1990
1990
We investigated the antiproliferative effect of 10-hydroxycamptothecin (HCPT), an alkaloid isolated from Camptotheca acuminata… 
1989
1989
DNA topoisomerase I (Topo I) can exist in several different molecular weight forms in human leukemic cells. The Mr 98,000 form of…